{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-041556","form_type":"8-K","ticker":"MLTX","cik":"0001821586","company_name":"MoonLake Immunotherapeutics","filed_at":"2023-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.866393+00:00","generated_at":"2026-06-14T20:01:10.359483+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MoonLake Immunotherapeutics amends equity plans to provide automatic vesting upon change of control","bullets":["Effective May 15, 2023, Board amended Employee Share Participation Plan and Stock Option Plan to include single-trigger vesting upon Change of Control.","Amendments apply to all outstanding and future equity awards, including those to named executive officers.","Awards will vest in full automatically upon a Change of Control as defined in the Plans.","Change aligns compensation arrangements with market practice per the Company's review."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-041556","json":"https://secwatch.observer/filing/0001213900-23-041556.json","markdown":"https://secwatch.observer/filing/0001213900-23-041556.md","text":"https://secwatch.observer/filing/0001213900-23-041556.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1821586/000121390023041556/0001213900-23-041556-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1821586/000121390023041556/ea178889-8k_moonlake.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T20:01:10.359483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}